 | |
| Formation | 5 July 2013 |
|---|---|
| Headquarters | One Canada Square, Canary Wharf, London, England[1] |
Parent organization | Department of Health and Social Care |
| Website | www |
Genomics England is a British company set up and owned by the United Kingdom Department of Health and Social Care to run the 100,000 Genomes Project.[2] The project aimed in 2014 to sequence 100,000 genomes from NHS patients with a rare disease and their families, and patients with cancer. An infectious disease strand is being led by Public Health England.[3][4][5]
In the summer of 2019, Chris Wigley was appointed CEO of Genomics England, starting in October 2019.[6] Wigley is a former McKinsey executive known for applying machine learning and artificial intelligence technology.[7]
- ^ "Contact us". Genomics England. Retrieved 25 November 2023.
- ^ McGrath, J.A. (2016). "Rare inherited skin diseases and the Genomics England 100 000 Genome Project". British Journal of Dermatology. 174 (2): 257–258. doi:10.1111/bjd.14362. ISSN 0007-0963. PMID 26871914.
- ^ Moran, Nuala (2014). "10,000 rare-disease genomes sequenced". Nature Biotechnology. 32 (1): 7. doi:10.1038/nbt0114-7. ISSN 1087-0156. S2CID 33053129.
- ^ Ainsworth, Claire (2015). "Q&A: Mark Caulfield". Nature. 527 (7576): S5. Bibcode:2015Natur.527S...5A. doi:10.1038/527S5a. ISSN 0028-0836. PMID 26536223.
- ^ Marx, Vivien (2015). "The DNA of a nation". Nature. 524 (7566): 503–505. Bibcode:2015Natur.524..503M. doi:10.1038/524503a. ISSN 0028-0836. PMID 26310768.
- ^ "Genomics England Appoints AI Specialist Chris Wigley as CEO". 27 July 2019.
- ^ "Chris Wigley appointed CEO of Genomics England | Genomics England". 26 July 2019.